Read more about the article 23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company that has used…

Continue Reading23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
Read more about the article Post Office data breach: Hundreds of victims to get compensation
Post Office data breach: Hundreds of victims to get compensation

Post Office data breach: Hundreds of victims to get compensation

Emma SimpsonBusiness correspondent, BBC NewsThe Post Office has agreed compensation for hundreds of former sub-postmasters after accidentally leaking their names and addresses on its corporate website.The data breach was revealed…

Continue ReadingPost Office data breach: Hundreds of victims to get compensation
Read more about the article Struggling DNA testing firm 23andMe to be bought for $256m
Struggling DNA testing firm 23andMe to be bought for $256m

Struggling DNA testing firm 23andMe to be bought for $256m

Lily JamaliNorth America Technology Correspondent•@lilyjamaliReporting fromSan Francisco, CAReutersThe DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).It comes two…

Continue ReadingStruggling DNA testing firm 23andMe to be bought for $256m

End of content

No more pages to load